Outcomes of In-bag Transvaginal Extraction in a Series of 692 Laparoscopic Myomectomies: Results from a Large Retrospective Analysis.

Complications In-bag transvaginal extraction Laparoscopic myomectomy Posterior colpotomy Surgical specimen retrieval

Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 22 05 2022
revised: 12 09 2022
accepted: 15 09 2022
pubmed: 24 9 2022
medline: 15 12 2022
entrez: 23 9 2022
Statut: ppublish

Résumé

Transvaginal extraction is a feasible method to remove surgical specimen. In this study, we aim to report our experience with in-bag transvaginal specimen retrieval after laparoscopic myomectomy over the past 15 years. Single-center retrospective analysis. Academic hospital. Women who underwent laparoscopic myomectomy from January 2005 to April 2021. Posterior colpotomy and in-bag transvaginal extraction of the surgical specimen. We collected and analyzed data about patients' characteristics, main indication for surgery, and intra- and postoperative (within 30 days) complications. A total of 692 women underwent transvaginal specimen retrieval after laparoscopic myomectomy (mean largest myoma diameter: 6.64 ± 2.21 cm; mean specimen weight: 177 ± 140 g; mean operative time: 84.1 ± 37.1 minutes; mean blood loss: 195 ± 191 mL). Within 30-days, we reported the following colpotomy-related complications: a total of 4 cases (0.6%) of vaginal bleeding, 3 of which resolved spontaneously (1 case required readmission with new colporrhaphy under general anesthesia), and 2 cases (0.3%) of vaginal pain, with no underlying cause identified on physical examination and pelvic ultrasound. Specimen weight was positively correlated with longer operative time, intraoperative blood loss, and length of hospital stay. Posterior colpotomy and in-bag transvaginal extraction can be considered a feasible option for retrieval of surgical specimens after laparoscopic myomectomy.

Identifiants

pubmed: 36150421
pii: S1553-4650(22)00369-7
doi: 10.1016/j.jmig.2022.09.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1331-1338

Informations de copyright

Copyright © 2022 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Antonio Simone Laganà (AS)

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Women and Children Hospital, University of Insubria, Varese (Drs. Laganà, Casarin, Cromi, Guerrisi, Flamminio, and Ghezzi), Italy. Electronic address: antoniosimone.lagana@uninsubria.it.

Jvan Casarin (J)

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Women and Children Hospital, University of Insubria, Varese (Drs. Laganà, Casarin, Cromi, Guerrisi, Flamminio, and Ghezzi), Italy.

Stefano Uccella (S)

Department of Obstetrics and Gynaecology, AOUI Verona, University of Verona, Verona (Drs. Uccella and Garzon), Italy.

Simone Garzon (S)

Department of Obstetrics and Gynaecology, AOUI Verona, University of Verona, Verona (Drs. Uccella and Garzon), Italy.

Antonella Cromi (A)

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Women and Children Hospital, University of Insubria, Varese (Drs. Laganà, Casarin, Cromi, Guerrisi, Flamminio, and Ghezzi), Italy.

Rocco Guerrisi (R)

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Women and Children Hospital, University of Insubria, Varese (Drs. Laganà, Casarin, Cromi, Guerrisi, Flamminio, and Ghezzi), Italy.

Filippo Di Flamminio (F)

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Women and Children Hospital, University of Insubria, Varese (Drs. Laganà, Casarin, Cromi, Guerrisi, Flamminio, and Ghezzi), Italy.

Fabio Ghezzi (F)

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Women and Children Hospital, University of Insubria, Varese (Drs. Laganà, Casarin, Cromi, Guerrisi, Flamminio, and Ghezzi), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH